$LNKS Be ready for a 1000% runner
1. 20M cash
2. MOU for acquisition signed (acquisition news could come any time this week).
3. Book value is way too high compared to trading price.
3. Insider holding solid chunk and haven’t sold in last 3 months.
4. Volume increased crazy
$BURU: Form S-1 Filed - Up to 115,000,000 Shares of Common Stock (or Pre-Funded Warrants to Purchase up to 115,000,000 Shares of Common Stock in lieu of Common Stock)
NUBURU continues to execute on balance sheet improvement.
The completion of the first tranche of the preferred equity restructuring reduces legacy liabilities by ~ $8.4M and represents a meaningful step toward long-term financial stability and value creation
🔗 https://t.co/0w7Q2I8gHx
#DefenseTech #SaaS #OperationalResilience #DefenseTech #BlueLaser
#Growth #Innovation
$Mten this could run like $Nakd naked brands in past one of the meme stocks from .06 .50 and .50 to 4 buck within month only because it was dirt cheap and so many shorts has to cover due to price jump and it started fireworks 🎇. it could be very interesting #Survivor2026#fomo
🚀 Salesforce invests $1 billion in Singapore’s AI sector over next 5 years 🤖💼
Salesforce $CRM is taking a big leap into AI, committing to invest $1 billion in Singapore’s AI industry. This initiative will accelerate digital transformation and promote the adoption of Salesforce's AI solution, Agentforce.
🔹 Why it matters?
- The investment will help combat challenges like an aging population and promote job growth in key sectors.
- Salesforce has already made strides with innovations like AIOps Agents and LLMs that enhance site performance and optimize code.
- The move is also part of Salesforce’s broader strategy to enhance Hyperforce in Singapore for better data residency compliance.
🔥 What's next?
With Agentforce 2dx now unveiled, Salesforce is positioning itself at the forefront of proactive AI capabilities. Plus, a new partnership with Singapore Airlines will improve customer case management systems.
Goldman Sachs analyst Kash Rangan set a $400 target for Salesforce stock, which has surged 9.35% in the last 6 months. 📈
Image via Shutterstock.
$ADTX Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.
#boom
🤩 We’ve teamed up with @Nasdaq to help increase exposure of their Semiconductor, Cybersecurity, AI, Crypto, and Nasdaq-100®️ indexes!!! Check them out on the new Nasdaq Education Hub in the Blossom app!
👀 Here’s what’s in the Nasdaq Semiconductor Index:
Anticipating Price Action on Stocks with Alternate Cashless Warrants
As alternate cashless warrants become more prevalent, we felt it was necessary to provide a more in depth explainer on what kind of price action to expect.
Alternate cashless warrants are fast becoming a go-to tool for desperate nano-cap companies seeking cash. These deals let warrant holders receive extra shares without any cash payment. Initially, the warrants come with a 1–3× multiplier. However, if the stock dips, reset clauses kick in—lowering the exercise price to the lowest recent VWAP (with a set floor) and can often boost the multiplier up to 10–30× of the original amount.
The result? A potential death spiral dilution effect.
We dissect the timeline into 3 distinct phases:
• Phase 0: Before any offering with cashless warrants, the stock might slowly decline if the market anticipates possible offering with cashless warrants.
• Phase 1: The announcement of an offering with alternate cashless warrants triggers an immediate price drop. However, since the cashless warrants still require shareholder approval in most cases, there can be technical bounces during this phase as traders wait for more clarity (e.g. if approvals are delayed).
• Phase 2: Once approval is in place (often coupled with a reverse split), the reset clauses activate. For example, AEON/ACON saw up to >9M extra shares hit the market—pushing the price down dramatically (up to a 95% drop).
• Phase 3: After the heavy selling finishes, the stock may experience a technical bounce as it overshoots to new equilibrium levels.
Understanding these phases and clearly delineating their start and finish can offer opportunities for both longs and shorts.
Full blog post linked here: https://t.co/48dTUXgZpE
List of current tickers and their current phases:
Phase 1 (warrants pending approval/reset/registration):
GNLN, PSTV, ZCAR, STSS, RNAZ, PTPI, SUNE, LGMK, HCTI, EFSH, DGLY, FMTO, APDN, AGMH, HEPA, RSLS
Phase 2 (active selling of cashless warrants):
SPGC, ICON, NVNI, ACON
Phase 3 (selling complete):
AEON, GCTK, REVB, RIME, UOKA, HMR (MGOL)
Innovation thrives in tough times, and ARK navigates geopolitical risks by tracking global economic and policy shifts. @CathieDWood shares examples of how ARK adapts to uncertainty when investing in our “February Fund mARKet Update Webinar.”
$ADTX Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.
#boom